# Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)

> **NCT02416193** · PHASE2 · TERMINATED · sponsor: **Loyola University** · enrollment: 56 (actual)

## Conditions studied

- Diabetes
- Executive Dysfunction

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT02416193
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-23
- **Primary completion:** 2018-07-12
- **Final completion:** 2018-07-12
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** the study was halted prematurely due to slow recruitment and expiration of funding
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416193, "Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02416193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*